SUWANEE, Ga., Jan. 31, 2017 -- Digirad Corporation (NASDAQ:DRAD) today announced a quarterly cash dividend of $0.05 per share. The dividend is payable on February 28, 2017 to shareholders of record as of February 15, 2017.
About Digirad
Digirad delivers convenient, effective, and efficient healthcare solutions on an as needed, when needed, and where needed basis. Digirad’s diverse portfolio of mobile healthcare solutions and medical equipment and services, including diagnostic imaging and patient monitoring, provides hospitals, physician practices, and imaging centers throughout the United States access to technology and services necessary to provide exceptional patient care in the rapidly changing healthcare environment. For more information, please visit www.digirad.com.
Contact Information: Digirad Corporation — Investors Jeff Keyes Chief Financial Officer [email protected] 858-726-1600


Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 



